AI-driven platform analysing multi-omics data for early-stage drug discovery

RESEARCH

16 Nov 2025

New AI Platforms Push Drug Discovery Into Higher Gear

Athos and Genomics boost multi omics discovery, but broad adoption is early and risks around AI data and oversight remain

Athos Therapeutics facility supporting AI driven multi omics research

INNOVATION

11 Nov 2025

AI Is Rewriting the Race for Multi Omics Discovery

Athos, Illumina, and Xeptiva advance AI driven multi omics as early adopters seek an R&D edge

Genetic code visualization illustrating AI powered target discovery

INNOVATION

24 Oct 2025

Mystra Ignites New Hopes for Faster Drug Targets

Mystra promises faster target analysis as sector adoption remains gradual

Digital pill illustration representing AI driven drug design and pharmaceutical research

TECHNOLOGY

20 Oct 2025

Can AI Reboot the Pace of Pharma Research?

AI platforms accelerate early drug design and push pharma toward a faster, more digitally driven R&D future

Nabla Bio office with researchers working on AI driven biologics discovery

INSIGHTS

15 Oct 2025

Inside the AI Rush Reshaping US Biotech

Nabla Bio and Takeda expand their second AI biologics deal as momentum grows and biotech firms rush to modernize discovery

Cancer cells illustration representing AI driven oncology research and targeting

INVESTMENT

19 May 2025

New Funding Pushes AI to the Heart of Oncology

Pathos AI’s major 2025 financing and strategic partnerships signal a faster, data driven shift in oncology development

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.